Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care

被引:27
作者
Snyder, Margie E. [2 ]
Earl, Tara R. [3 ]
Gilchrist, Siobhan [1 ,6 ,7 ]
Greenberg, Michael [3 ]
Heisler, Holly [3 ,4 ]
Revels, Michelle [3 ]
Matson-Koffman, Dyann [5 ,8 ]
机构
[1] Ctr Dis Control & Prevent, Appl Res & Evaluat Branch, Div Heart Dis & Stroke Prevent, Atlanta, GA 30341 USA
[2] Purdue Univ, Indianapolis, IN USA
[3] ICF Int Inc, Atlanta, GA USA
[4] ICF Int Inc, Cambridge, MA USA
[5] Ctr Dis Control & Prevent, Off Associate Director Sci, Atlanta, GA 30341 USA
[6] IHRC Inc, Atlanta, GA USA
[7] Columbus Technol & Serv Inc, Atlanta, GA USA
[8] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30341 USA
来源
PREVENTING CHRONIC DISEASE | 2015年 / 12卷
关键词
PHARMACISTS;
D O I
10.5888/pcd12.140504
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Collaborative drug therapy management agreements are a strategy for expanding the role of pharmacists in team-based care with other providers. However, these agreements have not been widely implemented. This study describes the features of existing provider-pharmacist collaborative drug therapy management practices and identifies the facilitators and barriers to implementing such services in community settings. We conducted in-depth, qualitative interviews in 2012 in a federally qualified health center, an independent pharmacy, and a retail pharmacy chain. Facilitators included 1) ensuring pharmacists were adequately trained; 2) obtaining stakeholder (eg, physician) buy-in; and 3) leveraging academic partners. Barriers included 1) lack of pharmacist compensation; 2) hesitation among providers to trust pharmacists; 3) lack of time and resources; and 4) existing informal collaborations that resulted in reduced interest in formal agreements. The models described in this study could be used to strengthen clinical-community linkages through team-based care, particularly for chronic disease prevention and management.
引用
收藏
页数:9
相关论文
共 19 条
[1]  
American Pharmacists Association, 2008, J Am Pharm Assoc (2003), V48, P341, DOI 10.1331/JAPhA.2008.08514
[2]  
[Anonymous], 2012, AHRQ PUBLICATION
[3]   Definition of medication therapy management: Development of professionwide consensus [J].
Bluml, Benjamin M. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2005, 45 (05) :566-572
[4]   Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements [J].
Bluml, Benjamin M. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2013, 53 (02) :E132-+
[5]  
Carmichael JM, 1997, PHARMACOTHERAPY, V17, P1050
[6]  
Centers for Disease Control and Prevention, 2013, STAT LAW FACT SHEET
[7]   Comparison of an anticoagulation clinic with usual medical care -: Anticoagulation control, patient outcomes, and health care costs [J].
Chiquette, E ;
Amato, MG ;
Bussey, HI .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1641-1647
[8]   US Pharmacists' Effect as Team Members on Patient Care Systematic Review and Meta-Analyses [J].
Chisholm-Burns, Marie A. ;
Lee, Jeannie Kim ;
Spivey, Christina A. ;
Slack, Marion ;
Herrier, Richard N. ;
Hall-Lipsy, Elizabeth ;
Zivin, Joshua Graff ;
Abraham, Ivo ;
Palmer, John ;
Martin, Jennifer R. ;
Kramer, Sandra S. ;
Wunz, Timothy .
MEDICAL CARE, 2010, 48 (10) :923-933
[9]   Effect of a pharmacist-managed diabetes care program in a free medical clinic [J].
Davidson, MB ;
Karlan, VJ ;
Hair, TL .
AMERICAN JOURNAL OF MEDICAL QUALITY, 2000, 15 (04) :137-142
[10]  
Giberson S., 2011, Improving patient and health system outcomes through advanced pharmacy practice: A report to the U.S. Surgeon General. Office of the Chief Pharmacist